Oligonucleotide therapeutics create complex impurity profiles. Truncated sequences, deletion products, modified species, degradation products, and process-related impurities can resemble the intended product. Some differ by small mass shifts. Others coelute or appear across multiple charge states.
LC/MS helps analytical scientists move beyond a purity estimate. It connects chromatographic separation with mass-based evidence, allowing teams to ask which impurities are present, how abundant they appear, and what they may reveal about synthesis, purification, formulation, or storage.
Why Impurity Profiling Is Difficult
Oligonucleotides are large, highly charged molecules. Many also contain chemical modifications designed to improve stability or activity. These features complicate LC/MS analysis because they can produce multiple charge states, adducts, complex isotope patterns, and closely related impurity signals.
Common impurity classes may include shortmers, longmers, deletion products, depurination-related products, oxidation products, desulfurization products, and protecting-group-related impurities. The exact profile depends on the oligonucleotide chemistry, synthesis route, purification strategy, formulation, and storage conditions.
This complexity means one technique rarely answers every question. LC-UV may show whether impurities exist. Capillary electrophoresis or anion exchange may provide useful orthogonal separation. LC/MS can help when the lab needs identity, structural evidence, or process insight.
Working in analytical science?
Register for a FREE Separation Science account to subscribe to the Separation Science Newsletter.
Where LC/MS Adds Value
LC/MS is most useful when impurity profiling needs more than a chromatographic peak area. It can help confirm the full-length product, assign likely impurity identities, compare impurity patterns across batches, and investigate unexpected peaks.
In development, LC/MS can guide process changes. A recurring deletion product may point to synthesis inefficiency. A degradation product can suggest storage or formulation stress. A low-level impurity may need further tracking if it increases during scale-up.
In QC, LC/MS can support investigations, characterization, or method development even when routine release testing uses simpler validated assays. This distinction is important as LC/MS often strengthens understanding, but it does not need to replace every routine purity method.
Separation Mode Shapes the Result
The separation method determines which impurities the MS can detect cleanly. Ion-pair reversed-phase LC remains the primary LC/MS approach for many oligonucleotide workflows because it helps retain and resolve highly polar, charged molecules. It can separate many full-length products from related impurities, but the ion-pairing reagents can suppress MS response, increase background, and affect system cleanliness.
HILIC is growing in use for specific applications, especially where it provides useful orthogonal selectivity. It may help with selected impurity profiling challenges, but it should not be framed as a broad replacement for IP-RP. Ion-pairing HILIC remains an emerging niche rather than a routine default.
No separation mode solves every impurity problem. IP-RP may suit many truncated sequences and closely related species. Meanwhile, HILIC can help in selected cases, and capillary electrophoresis or anion exchange can reveal charge- or size-based differences that LC/MS methods may miss. The best workflow starts with the impurity question, not the platform.
Sample Preparation Matters
Impurity profiling starts before injection. Salts, counterions, excipients, extraction residues, and formulation components can affect retention, ionization, adduct formation, and carryover. These effects can hide low-level impurities or create artifacts.
For bioanalytical samples, proteins and matrix components add another layer of difficulty. For drug substance or drug product samples, the matrix may look simpler, but concentrated samples can still drive carryover, adsorption, or source contamination.
A practical method should test sample dilution, solvent compatibility, recovery, stability, carryover, adduct formation, and matrix effects. These checks help analysts distinguish true impurity signals from handling or method artifacts.
Identification Requires Multiple Clues
Accurate mass can narrow possible identities, but it may not provide enough evidence on its own. Oligonucleotide impurities can produce overlapping charge states, sodium or potassium adducts, and related fragment patterns. Some modifications create small mass differences that require strong data quality and careful review.
MS/MS can support sequence confirmation and structural assignment. Retention behavior, isotope distribution, charge-state pattern, fragment ions, expected process chemistry, and comparison with standards can all strengthen confidence.
Informatics can help by predicting masses, assigning charge states, matching fragments, and organizing related species. But automated assignments still need expert review. A consistent rule set can still produce the wrong answer if the search space, adduct settings, or acceptance criteria do not match the chemistry.
Quantification Needs Clear Limits
LC/MS can support impurity quantification, but the result needs careful framing. Differential ionization is a well-known limitation of MS-based quantification. Different impurities may not ionize like the parent oligonucleotide, even when they are structurally related. Modifications, charge states, adducts, coelution, and ion-pairing behavior can all affect signal.
When authentic standards exist, quantification becomes stronger. When they do not, relative quantification may still help compare batches, stress conditions, or process changes. The method should state what the number represents.
This distinction is important as a method may work well for detection and tentative identification but require more validation before it supports precise quantification. Analysts should avoid treating every LC/MS peak area as an equivalent measure of abundance.
Building a Practical Workflow
A useful LC/MS impurity workflow connects product knowledge with method design. The first step is to define the important impurity classes. Synthesis chemistry, modification type, purification approach, degradation pathways, and prior batch data can all guide the method.
From there, teams can select a primary separation mode, add orthogonal methods where needed, optimize MS conditions, and define identification criteria. System suitability should reflect the method’s purpose. For impurity profiling, critical pair resolution, low-level detection, mass accuracy, and carryover may be more important more than retention time alone.
The workflow should also define how results will be used. Screening, investigation, relative comparison, structural confirmation, and validated quantification each require different levels of evidence.
What Analytical Scientists Should Take Away
LC/MS impurity profiling for oligonucleotides is most valuable when it answers questions that simpler assays cannot. It can help identify related species, explain process trends, support degradation studies, and strengthen product understanding.
The main challenge is not producing more data. It is producing interpretable data. Strong workflows control separation, sample handling, ionization, adducts, carryover, and assignment rules.
For oligonucleotide therapeutics, LC/MS should form part of a broader impurity strategy. Its best role is to clarify what is present, connect impurities to process or degradation pathways, and support better analytical and manufacturing decisions.
